Treatment of advanced prostate cancer
MY Teo, DE Rathkopf, P Kantoff - Annual review of medicine, 2019 - annualreviews.org
The therapeutic landscape of prostate cancer has been transformed over the last decade by
new therapeutics, advanced functional imaging, next-generation sequencing, and better use …
new therapeutics, advanced functional imaging, next-generation sequencing, and better use …
Oligometastatic prostate cancer: definitions, clinical outcomes, and treatment considerations
The oligometastatic state has been proposed as an intermediate stage of cancer spread
between localized disease and widespread metastases. With improvements in diagnostic …
between localized disease and widespread metastases. With improvements in diagnostic …
Postoperative mortality among surgical patients with COVID-19: a systematic review and meta-analysis
SM Abate, B Mantefardo, B Basu - Patient safety in surgery, 2020 - Springer
Background The coronavirus disease 2019 (COVID-19) pandemic puts perioperative
providers and staff at risk of viral exposure to severe acute respiratory syndrome coronavirus …
providers and staff at risk of viral exposure to severe acute respiratory syndrome coronavirus …
[HTML][HTML] Outcomes of cytoreductive radical prostatectomy for oligometastatic prostate cancer on prostate-specific membrane antigen positron emission tomography …
Background De novo oligometastatic prostate cancer (omPCa) on prostate-specific
membrane antigen (PSMA) positron emission tomography (PET) is a new disease entity and …
membrane antigen (PSMA) positron emission tomography (PET) is a new disease entity and …
Local therapy improves survival in metastatic prostate cancer
Background Treatment of the primary, termed local therapy (LT), may improve survival in
metastatic prostate cancer (mPCa) versus no local therapy (NLT). Objective To assess …
metastatic prostate cancer (mPCa) versus no local therapy (NLT). Objective To assess …
Feasibility and safety of radical prostatectomy for oligo‐metastatic prostate cancer: the Testing Radical prostatectomy in men with prostate cancer and oligo …
Objectives To test the feasibility of randomisation to radical prostatectomy (RP) plus pelvic
lymphadenectomy in addition to standard‐of‐care (SOC) systemic therapy in men with …
lymphadenectomy in addition to standard‐of‐care (SOC) systemic therapy in men with …
Oligometastatic prostate cancer: reality or figment of imagination?
The term “oligometastatic prostate cancer” refers to a heterogeneous group of disease states
currently defined solely on the basis of clinical features. Oligorecurrent disease, de novo …
currently defined solely on the basis of clinical features. Oligorecurrent disease, de novo …
Radical prostatectomy in men with oligometastatic prostate cancer: results of a single-institution series with long-term follow-up
In the absence of data from randomized trials, the role of local treatment in metastatic
prostate cancer (PCa) is gaining interest. Our study aimed to assess perioperative and long …
prostate cancer (PCa) is gaining interest. Our study aimed to assess perioperative and long …
Does cytoreductive prostatectomy really have an impact on prognosis in prostate cancer patients with low-volume bone metastasis? Results from a prospective case …
The impact of cytoreductive radical prostatectomy (CRP) on oncological outcomes in
patients with prostate cancer (PCa) and distant metastases has been demonstrated by …
patients with prostate cancer (PCa) and distant metastases has been demonstrated by …
Novel insights into the management of oligometastatic prostate cancer: a comprehensive review
A Battaglia, G De Meerleer, L Tosco, L Moris… - European urology …, 2019 - Elsevier
Context The current standard of care for metastatic prostate cancer (PCa) is androgen
deprivation therapy (ADT) plus either docetaxel or abiraterone. Growing evidence suggests …
deprivation therapy (ADT) plus either docetaxel or abiraterone. Growing evidence suggests …